Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KJ015 + unspecified PD-1 antibody |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KJ015 | HER2 (ERBB2) Antibody 76 | KJ015 is a anti-ERBB2 (HER2) biparatopic antibody targeting two non-overlapping ERBB2 (HER2) epitopes, which inhibits downstream Erk1/2 and Mek1/2 phosphorylation and potentially induces cytotoxicity in tumor cells and inhibits tumor growth (PMID: 39381966). | ||
unspecified PD-1 antibody | Experimental PD-1 antibody | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 122 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|